CUSTOM SYNTHESIS AGREEMENT By and Between Merck & Co., Inc. and WuXi PharmaTech Co., Ltd.Custom Synthesis Agreement • August 8th, 2007 • WuXi PharmaTech (Cayman) Inc. • Pharmaceutical preparations • New Jersey
This Agreement (the “Agreement”) confirms the mutual understanding by and between Merck & Co., Inc., a New Jersey corporation having a place of business at One Merck Drive, Whitehouse Station, NJ 08889 (“MERCK”), and WuXi PharmaTech Co., Ltd., a Chinese corporation having a place of business at Building 4, 2nd Floor A, 253 AiDu Road, Shanghai WaiGaoQiao Free Trade Zone, Shanghai, China, PS 200131 (“PHARMATECH”).
EXHIBIT 10.6 ZFP CUSTOM SYNTHESIS AGREEMENT THIS ZFP CUSTOM SYNTHESIS AGREEMENT dated as of ___________, 1999 (the "Agreement"), is entered into between SANGAMO BIOSCIENCES, INC., a Delaware corporation ("Sangamo"), having a place of business at Point...Custom Synthesis Agreement • February 24th, 2000 • Sangamo Biosciences Inc • Services-commercial physical & biological research • California
ContractCustom Synthesis Agreement • October 31st, 2006 • Cerus Corp • Biological products, (no disgnostic substances)
[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.
